Showing 20 of 126 recruiting trials for “b-lymphoblastic-leukemialymphoma-with-tv11q233”
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
👨⚕️ Seth E. Karol, MD, St. Jude Children's Research Hospital📍 3 sites📅 Started Dec 2024View details ↗
Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
🏥 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Oct 2024View details ↗
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
👨⚕️ He Huang, MD, First Affiliated Hospital of Zhejiang University📍 1 site📅 Started Oct 2024View details ↗
Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
👨⚕️ Sanbin Wang, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Jun 2024View details ↗
Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL
👨⚕️ Jianxiang Wang, Dr, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jun 2024View details ↗
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →